Condition: Diabetes Mellitus, Type 1 · Sponsor: Milton S. Hershey Medical Center
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of the CLEAR study is to determine the effect on counterregulatory responses (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of hypoglycemia (IAH). IAH affects 20-25% of adults with T1D, and rises with increasing duration of T1D.
This description comes directly from the study's public registry record.
Abid Kazi, PhD · 717-531-0003 · akazi@pennstatehealth.psu.edu
Venus Grella, MPH · 717-531-0003 · vgrella@pennstatehealth.psu.edu
Always discuss trial participation with your own doctor first.
| University of California, San Diego | La Jolla, California, United States | Recruiting |
| AdventHealth | Orlando, Florida, United States | Recruiting |
| University of Kentucky | Lexington, Kentucky, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Melbourne | Fitzroy, Victoria, Australia | Recruiting |
| University of Leicester | Leicester, United Kingdom | Recruiting |
| University of Sheffield | Sheffield, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.